Similar Articles
661 Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis
662 Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review
663 Liver transplantation for hepatocellular carcinoma: Where do we stand?
664 Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma
665 Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
666 Mechanisms of hepatocellular carcinoma progression
667 Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma
668 Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review
669 ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma
670 Role and mechanism of circ-PRKCI in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA